International Journal of
Reproductive Biomedicine
Tue, Apr 23, 2024
[Archive]
Volume 13, Issue 10 (10-2015)
IJRM 2015, 13(10): 591-604 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Jalilian A, Kiani F, Sayehmiri F, Sayehmiri K, Khodaee Z, Akbari M. Prevalence of polycystic ovary syndrome and its associated complications in Iranian women: A meta-analysis. IJRM 2015; 13 (10) :591-604
URL: http://ijrm.ir/article-1-599-en.html
URL: http://ijrm.ir/article-1-599-en.html
Anahita Jalilian1 
, Faezeh Kiani2 , Fatemeh Sayehmiri2 , Kourosh Sayehmiri * 3, Zahra Khodaee2 , Malihe Akbari4
, Faezeh Kiani2 , Fatemeh Sayehmiri2 , Kourosh Sayehmiri * 3, Zahra Khodaee2 , Malihe Akbari4
1- Department of Obstetrics and Gynecology, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran
2- Student Research Committee, Ilam University of Medical Sciences, Ilam, Iran
3- Department of Social Medicine, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran
4- Department of Nursing and Midwifery, Ilam University of Medical Sciences, Ilam, Iran
2- Student Research Committee, Ilam University of Medical Sciences, Ilam, Iran
3- Department of Social Medicine, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran
4- Department of Nursing and Midwifery, Ilam University of Medical Sciences, Ilam, Iran
Abstract: (3931 Views)
Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age and is the most common cause of infertility due to anovulation. There is no single criterion for the diagnosis of this syndrome.
Objective: The purpose of this study was to investigate the prevalence of PCOS and its associated complications in Iranian women using meta-analysis method.
Materials and Methods: Prevalence of PCOS was investigated from the SID, Goggle scholar, PubMed, Magiran, Irandoc, and Iranmedex, and weighting of each study was calculated according to sample size and prevalence of the binomial distribution. Data were analyzed using a random-effects model meta-analysis (Random effects model) and the software R and Stata Version 11.2.
Results: 30 studies conducted between the years 2006 to 2011 were entered into meta-analysis. The total sample size was 19, 226 women aged between 10-45 years. The prevalence of PCOS based on National institute of child health and human disease of the U.S was, 6.8% (95 % CI: 4.11–8.5), based on Rotterdam was 19.5% (95 % CI: 2.24-8.14), and based on ultrasound was 4.41% (95% CI: 5.68-4.14). Also, the prevalence of hirsutism was estimated to be 13%, acne 26%, androgenic alopecia 9%, menstrual disorders 28%, overweight 21%, obesity 19%, and infertility 8%.
Conclusion: The prevalence of PCOS in Iran is not high. However, given the risk of complications such as heart disease - cardiovascular and infertility, prevention of PCOS is important; we suggest that health officials must submit plans for the community in this respect.
Objective: The purpose of this study was to investigate the prevalence of PCOS and its associated complications in Iranian women using meta-analysis method.
Materials and Methods: Prevalence of PCOS was investigated from the SID, Goggle scholar, PubMed, Magiran, Irandoc, and Iranmedex, and weighting of each study was calculated according to sample size and prevalence of the binomial distribution. Data were analyzed using a random-effects model meta-analysis (Random effects model) and the software R and Stata Version 11.2.
Results: 30 studies conducted between the years 2006 to 2011 were entered into meta-analysis. The total sample size was 19, 226 women aged between 10-45 years. The prevalence of PCOS based on National institute of child health and human disease of the U.S was, 6.8% (95 % CI: 4.11–8.5), based on Rotterdam was 19.5% (95 % CI: 2.24-8.14), and based on ultrasound was 4.41% (95% CI: 5.68-4.14). Also, the prevalence of hirsutism was estimated to be 13%, acne 26%, androgenic alopecia 9%, menstrual disorders 28%, overweight 21%, obesity 19%, and infertility 8%.
Conclusion: The prevalence of PCOS in Iran is not high. However, given the risk of complications such as heart disease - cardiovascular and infertility, prevention of PCOS is important; we suggest that health officials must submit plans for the community in this respect.
Type of Study: Original Article |
References
1. Asgharnia M, Mirblook F, Ahmad Soltani M. The prevalence of polycystic ovary syndrome (PCOS) in high school students in Rasht in 2009 according to NIH criteria. Int J Fertil Steril 2011; 4: 156-159.
2. Lankarani M, Valizadeh N, Heshmat R, Shafaee AR, Amini MR, Ardeshir Larijani MB, et al. Evaluation of dyslipidemia in polycystic ovary syndrome. J Diabetes Metab Disord 2005; 4: E11+E11i-E11x.
3. Arshad M, Moradi S, Ahmmadkhani A, Emami Z. Increased prevalence of depression in women with polycystic ovary syndrome. Iranian Journal of Endocrinology and Metabolism 2012; 13: 582-586.
4. Haji Shafiha M, Zabiri T, Salari Lak SH. Investigating validity criteria of vaginal ultrasound (ovarian volume, the ovarian stroma and the stromal surface of the ovary) in the diagnosis of polycystic ovary syndrome. Urmia Medical Journal 2007; 3: 538-543.
5. Taghavi M, Fatemi S. Macroprolactinemia accompany in patients with hyperandrogenemic symptoms. Iranian Journal of Endocrinology and Metabolism 2008; 10: 273-276.
6. Arefi S. PCO prevalence and association with menstrual irregularity in adolescence. J Reprod Infertil 2000; 5: 57-62.
7. Aali B, Naderi T. Evaluation of clinical, ultrasound and laboratory features of PCOS in Kerman in 1381. Iranian Journal of Endocrinology and Metabolism 2004; 6: 153-161.
8. Naderi T, Akbarzadeh M, Dabagh Manesh M, Tabatabaei H, Zareh Z. Frequency of facial and body acne in 14- to 18- year-old female high school students and its relationship to polycystic ovary syndrome. JDC 2011; 2: 124-131.
9. Mehrabian F, Khani B, Kelishadi R, Ghanbari E. The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynol Pol 2011; 62: 238–242.
10. Ramezani Tehrani F, Simbar M, Tohidi M, Hosseinpanah F, Azizi F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol 2011; 9: 39. [DOI:10.1186/1477-7827-9-39]
11. Rahmanpour H, Heidari R, mousavinasab S, sharifi F, Fekri S. The Prevalence of polycystic ovarian syndrome in 14-18 year old girls of Zanjan high schools, 2008. ZUMS Journal 2009; 17: 79-88.
12. Akbari D, Hossein Pour N. Causes of hirsutism in premenopausal women. JDC 2010; 1: 119-124.
13. Hashemipour M, Faghihimani S, Zolfaghary B, Hovsepian S, Ahmadi F, Haghighi S. Prevalence of Polycystic Ovary Syndrome in Girls Aged 14–18 Years in Isfahan, Iran. Horm Res 2004; 62: 278–282. [DOI:10.1159/000081842]
14. Zandi S, Farajzadeh S, Safari H. Prevalence of polycystic ovary syndrome in women with acne: hormone profiles and clinical findings. Journal of Pakistan Association of Dermatologists 2010; 20: 194-198.
15. Mohajeri Tehrani M, Parvizi M, Amini Moghadam S, Heshmat R, Shaban Nejad-Khas Z, Golchin M. The prevalence of polycystic ovary syndrome in Iranian women with gestational diabetes: a pilot study. Iranian Journal of Diabetes and Lipid Disorders 2009; 57-64.
16.
17. Salehpour S, Esmaeilnia Shirvani H, Entezari A. Evaluation of the prevalence of polycystic ovarian syndrome among adolescent (15-18 Years Old) girls in Tehran during 2005-2006. Int J Fertil Steril 2010; 4: 122-127.
18. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84: 4006-4011. [DOI:10.1210/jcem.84.11.6148]
19. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S. Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clinical Endocrinol Metab 2000; 85: 2434-2438. [DOI:10.1210/jc.85.7.2434]
20. Kumarapeli V, Seneviratne R de A, Wijoyaratne CN, Yapa RM, Dodampahala SH. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semiurban population in Srilanka. Am J Epidemiol 2008; 168: 321-328. [DOI:10.1093/aje/kwn137]
21. Azziz R, Woods KS, Reyan R, Key TJ, Knochenhauer ES, Yildiz B. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89: 2745-2749. [DOI:10.1210/jc.2003-032046]
22. Ansarin H, Aziz-Jalali MH, Rasi A, Soltani-Arabshahi R. Clinical presentation and etiologic factors of hirsutism in premenopausal Iranian women. Arch Iran Med 2007; 10: 7-13.
23. Noorbala MT, Kefaie P. The Prevalence of Hirsutism in Adolescent Girls in Yazd, Central Iran. Iran Red Crescent Med J 2010; 12: 111-117.
24. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25: 544–551. [DOI:10.1093/humrep/dep399]
25. Lowe P, Kovucs G, Howlett D. Incidence of polycystic ovaries and polycystic ovary syndrome amongst women in Melbourne, Australia. Aust N Z J Obstet Gynaecol 2005; 45: 17–19. [DOI:10.1111/j.1479-828X.2005.00334.x]
26. Gatee OB, Al Attia HM, Salama IA. Hirsutism in the united Arab Emirates: ahospital study. Post grad Med J 1996; 72: 168 -171. [DOI:10.1136/pgmj.72.845.168]
27. Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with unovulation and idiopathic hirsutism. Br Med J 1996; 293; 355-359. [DOI:10.1136/bmj.293.6543.355]
28. Farquhar CM, Birdsall M, Manning P, Mitchell JM, France JT. The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Aust N Z J Obstet Gynaecol 1994; 34: 67-72. [DOI:10.1111/j.1479-828X.1994.tb01041.x]
29. Khoury MY, Baracat EC, Pardin DP, Haidar MA, da Motta EL, de Lima GR. Polycystic ovary syndrome: Clinical and laboratory evaluation. Sao Paulo Med J 1996; 114: 1222-1225. [DOI:10.1590/S1516-31801996000400006]
30. Cibula D, Hill M, Vohradnikova O, Kuzel D, Fanta M, Zivny J. The role of androgens in determining acne severity in adult women. Br J Dermatol 2000; 143: 399-404. [DOI:10.1046/j.1365-2133.2000.03669.x]
31. Van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J. Endocrine features of polycystic ovary syndrome in a Random population sample of 14-16 years old adolescents. Hum Reprod 1999; 14: 2223-2229. [DOI:10.1093/humrep/14.9.2223]
32. Michelmore KF, Baren AH, Dunger DB, Vessey MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol 1999; 31: 779-786. [DOI:10.1046/j.1365-2265.1999.00886.x]
33. Farhadifar F, Lotfi M, Naseri K, Moghimi N, Yaghma'ee R, Rahimi A. Assessing the association between PCOS and glucose intolerance. The Scientific Journal of Kurdistan University of Medical Sciences 2006; 11: 45-55.
34. Sohrabvand F, Aqsa M, Haqolahi F, Baqeri M, Shariat M, Al-Yassin A, et al. Examining pregnancy process while using Metformin in pregnant women with infertility background due to polycystic ovary syndrome (PCOS). J Reprod Infertil 2006; 1: 23-29.
35. Glueck CJ, Wang P, Kobayashi S, Phillips H, Sieve-Smith L. Metformin therapy through pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002; 77: 520-525. [DOI:10.1016/S0015-0282(01)03202-2]
36. Pate C. Issues faced by women with hirsutism: state of the science. Health Care Women Int 2015; 24: 1-10
37. Mcknight E. The prevalence of hirsutism in young women. Lancet 1964; 1: 410-413.
37. Lobo RA. Hirsutism in Polycystic ovary syndrom current concepts. Clin Obtset Gynecol 199; 34: 817-826. [DOI:10.1016/S0140-6736(64)92789-8]
38. Kilkenny M, Merlin K, Plunkett A, Marks R. The prevalence of common skin conditions in Australian school students: 3 Acne vulgaris. Br J Dermatol 1998; 139: 840-845. [DOI:10.1046/j.1365-2133.1998.02510.x]
39. Bunker CB, Newton JA, Kilborn J, Patel A, Conway GS, Jacobs HS, et al. Most women with acne have polycystic ovaries. Br J Dermatol 1989; 121: 675-680. [DOI:10.1111/j.1365-2133.1989.tb08208.x]
40. Malkud S. A Hospital-based Study to Determine Causes of Diffuse Hair Loss in Women. J Clin Diagn Res 2015; 9: 1-4. [DOI:10.7860/JCDR/2015/14089.6170]
41. Rushton DH. Management of hair loss in woman. Dermatol Clin 1993; 11: 47-53.
42. Madani Sani F, Akhbari Z. A review of the factors influential in the development of PCOS. Quarterly Journal 2010; 47, 48: 49-54.
43. Conway GS, Hanorr JW, Jacobs HS. Heterognsity of the polycystic ovary syndrome: Clinical, endocrine and ultrasound feature in 556 pationts. Clin Endocrinol 1989: 30: 459-470. [DOI:10.1111/j.1365-2265.1989.tb00446.x]
44. Mirzaei F, Kazemi N. Investigate the prevalence of PCOS in women with type two,visiting Kerman diabetes clinic. Sci J Hamadan Univ Med Sci 2007; 14: 38-42.
45. Mor E, Zograbyan A, Saadat P. The Insulin resistant subpher. Type of polycystic ovory syndrome: clinical parameters and pathogenesis. Am J Obstet Gynecol 2004; 190: 1654-1660. [DOI:10.1016/j.ajog.2004.02.052]
46. Sajjadi Mirzaei S. Investigating the effect of treatment in patients with polycystic ovarian disease in hirsute women. Unpublished thesis, Tarbiat Modarres University, Tehran, Iran. Tesis.
47. Ramezani Tehrani F, Rashidi H, Azizi F. The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study. Reprod Biol Endocrinol 2011, 9: 144. [DOI:10.1186/1477-7827-9-144]
48. Farnaqy F, Seirafi H, Zarinpour N. Descriptive study of 110 patients with hirsutism in Razi Hospital in Tehran during the years of 2000-2001. Iran J Dermatol 2002; 6: 21-25.
49. Ghasemi N, Mortazavizadeh MR, Khorasani Gerdekoohi. Frequency of poly cystic ovary syndrome in patients with premenopausal breast cancer. Iran J Reprod Med 2010; 8: 86-89.
50. Kashanian M, Fazy Z, Pirak A. Evaluation of the relationship between gestational diabetes and a history of polycystic ovarian syndrome. Diabetes Res Clin Pract 2008; 80: 289–292. [DOI:10.1016/j.diabres.2007.12.022]
51. Ghaderi R, Sharifzadeh GH, Javanbakht P. Factors associated with hirsutism. Journal of Birjand University of Medical Sciences 2004; 11: 19-23.
52. Ghaderi R, Sharifzadeh GH, Faramarzi R. The relationship of with sex hormone levels. Journal of Birjand University of Medical Sciences 2004; 11: 11-16.
53. Akhyany M, Daneshpajouh M, Barzegari M, Ghandi N, Ghiasi M, Chenari Z, et al. The prevalence of hirsutism in female students of Tehran University School of Medicine. J Dermatol 2006; 9: 242-249.
54. Horri N, Farmani M, Haghighi S, Sattari G, Pournaqshband Z, Amini M. The prevalence of PCOS in women with type two diabetes in childbearing age. Iranian Journal of Diabetes and Lipid Disorders 2006; 5: 257-263.
55. Kalantar Hormozi MR, Siadatan SJ, Arya A, Dabbaghmaneh MH, Shams M, Sadegh-Alvad A, et al. Diabetes risk factors in Shiraz in 1386. Iranian Journal of Diabetes and Lipid Disorders 2007; 7: 159-166.
56. Naderi T, Akbarzadeh M, Dabbaghmaneh MH, Tabatabai HR. The prevalence of polycystic ovary syndrome phenotypes in high school female students in 1388. The Journal of Qazvin University of Medical Sciences 2011; 15: 61-67.
57. Jebraiili R., Galedar N. The prevalence of polycystic ovaries in patients with acne. Yafteh J 2001; 11: 35.
58. Jahanfar S, Maleki H, Mosavi AR, Jahanfar M. Leptin and its association with polycystic ovary syndrome: a twin study. Gynecol Endocrinol 2004; 18: 327-334. [DOI:10.1080/09513590410001667256]
59. Bani-Hashemi M, famili S, Nahidi Y. Investigating the causes of hirsutism in patients visiting Zahedan's Khatam-alanbia hospital from 1380 to 1382. Medical Journal of Mashhad University of Medical Sciences 2007; 50: 287–290.
60. Nqas Hosseini SH, Qavam A. Investigating the prevalence of PCOS among 1000 girls aged 18-15 years old in Kerman high schools. Unpublished thesis, Kerman University of Medical Sciences and Health Services, Kerman, Iran, 2004 Tesis.
61. Kamkhvah AF, Parvin N. Hormonal status in hirsute patients referred to the laboratory in Shahrekord in 2005. Journal of Shahrekord University of Medical Sciences. 2008; 10; 112-116.
62. Dadgostar H, Razi M, Aleyasin A, Alenabi T, Dahaghin S. The relation between athletic sports and prevalence of amenorrhea and oligomenorrhea in Iranian female athletes. Sports Med Arthrosc Rehabil Ther Technol 2009, 1: 16. [DOI:10.1186/1758-2555-1-16]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
